|
|
|
| Meta-analysis of Shensongyangxin Capsules treating viral myocarditis |
| ZHANG Shu-dan1 LI Qi2 DU Chang-sheng1 |
1.Department of Pharmacy,Dalian Hospital of Traditional Chinese Medicine in Liaoning Province,Dalian116013,China;
2.Department of Internal Medicine,the Third Hospital of Wafangdian in Liaoning Province,Dalian116300,China |
|
|
|
|
Abstract ObjectiveTo review systematically the effect and safety of Shensongyangxin Capsules treating viral myocarditis,and provide the related basis of evidence based medicine for Shensongyangxin Capsules treating viral myocarditis.MethodsPubMed,EMbase,Cochrane Library,CBM,WanFang,CNKI and VIP were retrieved using the computer for collecting RCT and CCT for database construction to November 4,2016,and all references included in the literature were traced.According to the inclusion and exclusion criteria,two reviewers screened and assessed independently the literature,and then the data was extracted.The data was given a Meta-analysis by using RevMan 5.3 software.Results12 study articles were included.Meta-analysis showed that the clinical curative effect of the Shensongyangxin group treating viral myocarditis was better than the Western medicine group(OR=3.19,95%CI:2.14-4.74,P＜0.01).The clinical curative effect of the Shensongyangxin group treating ventricular arrhythmia was better than the Western medicine group(OR=3.64,95%CI:2.50-5.30,P＜0.01).The occurrence rate of adverse events was lower and the reactions was low and mild in the Shensongyangxin group.ConclusionShensongyangxin Capsules has a significant curative effect treating viral myocarditis,and the safety is good.
|
|
|
|
|
|
| [1] |
Kuhl U，Schultheiss HP.Viral myocarditis：diagnosis，aetiology and management[J].Drugs，2009，69（10）：1287-1302.
|
| [2] |
Schultheiss HP，Kuhl U，Cooper LT.The management of myocarditis[J].Eur Heart J，2011，32（21）：2616-2625.
|
| [3] |
Cao Y，Xu X，Zhang P.Advances in the traditional Chinese medicine-based management of viral myocarditis[J].Cell Biochem Biophys，2015，73（1）：237-243.
|
| [4] |
Chen WJ，Hu DD，Liu L.Experimental research progress of treating viral myocarditis by Chinese medicine[J].Zhongguo Zhong Xi Yi Jie He Za Zhi，2013，33（10）：1438-1440.
|
| [5] |
王敬祝.参松养心胶囊治疗病毒性心肌炎60例临床观察[A]//中华中医药学会第三届国际络病学大会[C].北京，2007：440-441.
|
| [6] |
肖志刚，曹汉明.参松养心胶囊治疗病毒性心肌炎合并室性心律失常56例[J].医学创新研究，2007，4（23）：157-158.
|
| [7] |
刘娟.参松养心胶囊治疗室性期前收缩35例疗效观察[J].中国现代医药杂志，2007，9（12）：107-108.
|
| [8] |
熊刚.参松养心胶囊治疗心律失常型病毒性心肌炎24例临床观察[J].重庆医学，2008，37（2）：214-215.
|
| [9] |
职利琴.参松养心胶囊治疗病毒性心肌炎疗效分析[A]//第五届国际络病学大会[C].广州，2009：523.
|
| [10] |
李红.参松养心胶囊治疗成人病毒性心肌炎合并室性早搏的临床疗效观察[J].现代医药卫生，2009，25（7）：1072.
|
| [11] |
王显红.参松养心胶囊治疗急性病毒性心肌炎伴室性早搏的疗效观察[J].临床合理用药杂志，2009，2（12）：13-14.
|
| [12] |
刘宏军.参松养心胶囊治疗病毒性心肌炎68例临床观察[J].亚太传统医药，2010，6（12）：48-49.
|
| [13] |
张冬梅，孙秀月.参松养心胶囊治疗病毒性心肌炎合并室性心律失常疗效观察[J].中国误诊学杂志，2011，11（9）：2084-2085.
|
| [14] |
门晓燕.中西医结合治疗病毒性心肌炎心律失常和心功能远期疗效观察[J].实用心脑肺血管病杂志，2012，20（4）：719-720.
|
| [15] |
常敏.参松养心胶囊治疗儿童室性早搏80例观察[J].中国社区医师，2014，30（10）：90-92.
|
| [16] |
许冬阁，李超，孙笑卫，等.荣心丸联合参松养心胶囊治疗病毒性心肌炎导致的室性早搏的临床观察[J].中西医结合心血管病杂志（电子版），2015，3（27）：71-72.
|
| [17] |
Lv S，Rong J，Ren S，et al.Epidemiology and diagnosis of viral myocarditis[J].Hellenic J Cardiol，2013，54（5）：382-391.
|
| [18] |
张军平，吴美芳，吕仕超.我国病毒性心肌炎流行病学分析[A]//第二届全国中西医结合心血管病中青年论坛暨第二届黄河心血管病防治论坛[C].郑州，2011：34-38.
|
| [19] |
朱亚萍，丁彬彬，张军平.欧美、日本病毒性心肌炎的流行病学概况[A]//中华中医药学会心病分会全国第十二次学术年会暨中华中医药学会心病分会换届选举工作会议[C].无锡，2010：405-408.
|
| [20] |
张俊清，张军平.玉丹荣心丸治疗病毒性心肌炎疗效的系统评价[J].天津中医药，2009，26（2）：162-166.（收稿日期：2017-05-06本文编辑：许俊琴）
|
|
|
|
